Stocks in Focus on March 4, 2021: BDMS and SAWAD

Kaohoon Online has selected stocks with a potentially high growth for investors to consider on March 4, 2021.

 

KGI Securities has given an “Outperform” rating on Bangkok Dusit Medical Services Public Company Limited (BDMS) with a target price at ฿26.30.

KGI stated hat BDMS’ management foresees potential improvement from continued recovery in domestic and expat patients in mid-1Q21 after the second wave of COVID-19 outbreak in Thailand.

KGI expected the company’s 2021 sales to grow 9% YoY (2x Thailand’s GDP growth and boosted by return of fly-in patients). To reflect KGI’s new assumption, the security company raised its 2021F forecast 6.8% to a normalized profit of Bt7.08bn (+48.0% YoY).

 

Maybank Kim Eng has given a “BUY” recommendation on Srisawad Corporation Public Company Limited (SAWAD) with a target price at ฿84.00/share.

Maybank stated that it has a positive outlook on SAWAD’s strategy to increase insurance commission income to offset the reduction in late-penalty fees. The security company believed the partnership with the Government Savings Bank (GSB) could help SAWAD to grow its loan portfolio and reduce OPEX to offset decline in loan yields. SAWAD will book THB300m one-time gain from selling shares in subsidiaries in 1Q21. Raised Maybank’s FY21-22F forecasts by 7% each and revised up TP to THB84 (4.5x FY21E P/BV, 22x P/E and 22.5% long-term ROE). Key risks are weaker-than-expected fee income growth and asset quality.